Burn infection studies

Journal of Hospital Infection

Volumn 32, Issue 3, 1996, Pages 167-173

  Lowbury, E J ^a,b  

^a Birmingham Accident Research Cent   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBENICILLIN; PENICILLIN G;

ANTIBIOTIC PROPHYLAXIS; BURN; BURN INFECTION; CONTRACTURE; GRAFT FAILURE; GRAM NEGATIVE BACTERIUM; HISTORY OF MEDICINE; HUMAN; PROTEUS; PSEUDOMONAS AERUGINOSA; REVIEW; SAMPLING; SKIN GRAFT; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; WOUND DRESSING;

EID: 0029985359     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(96)90143-7     Document Type: Note

References (19)

1. Parker MT. Leonard Colebrook and his family. J Hosp Infect 1994; 28: 81-90.
2. Colebrook L, Duncan JM, Ross WPD. The control of infection in burns. Lancet 1948; i: 893-899.
3. Lowbury EJL. Wits versus genes: the continuing battle against infection (Evans Memorial Lecture, Ninth Annual Meeting, American Burn Association) J Trauma 1979; 19: 33-45.
4. Jackson DM, Lowbury EJL, Topley E. Chemotherapy for Streptococcus pyogenes infection of burns. Lancet 1951; ii: 705-711.
5. Jackson DM, Lowbury EJL, Topley E. Pseudomonas pyocyanea in burns; its role as a pathogen and the role of local polymyxin therapy. Lancet 1951; ii: 137-147.
6. Moyer CA, Bretano L, Gravens DJ et al. Treatment of large burns with 0·5% silver nitrate solution. Arch Surg 1965; 90: 812-867.
7. Lindberg RB, Moncreif JA, Switzer WE et al. The successful control of burn wound sepsis. J Trauma 1965; 5: 601-616.
8. Fox CL. Silver sulphadiazine: a new topical therapy for pseudomonas in burns. Arch Surg 1968; 96: 184-188.
9. Feller I, Burgess V, Callahan W et al. Use of vaccine and hyperimmune serum for protection against pseudomonas septicaemia. J Trauma 1964; 4: 451-460.
10. Alexander JW, Fisher JW, MacMillan BG et al. Prevention of invasive infection in burns with a new serum. Arch Surg 1969; 99: 249-256.
11. Burke JF. Isolation techniques and their effectiveness. In: Polk HC, Stone E. Eds Contemporary Burn Management. Boston: Little, Brown and company, 1971; p. 141.
12. Lowbury EJL, Jackson DM, Lilly HA et al. Alternative forms of local treatment for burns. Lancet 1971; ii: 1105-1111.
13. Bull JP. Revised analysis of mortality due to burns. Lancet 1971; ii: 1133-1134.
14. Lowbury EJL, Kidson A, Lilly HA et al. Sensitivity of Pseudomonas aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin. Lancet 1969; ii: 448-452.
15. Sykes RB, Richmond MH. Intergeneric transfer of β-lactamase gene between Pseudomonas aeruginosa and Escherichia coli. Nature (London) 1970; 226: 952-954.
16. Roe E, Jones RJ, Lowbury EJL. Transfer of antibiotic resistance between Pseudomonas aeruginosa, Escherichia coli, and other Gram-negative bacilli in burns. Lancet 1971, i: 149-152.
17. Lowbury EJL. Fact or Fashion? The rationale of the exposure method, vaccination and other anti-infective measures. (AB Wallace Memorial Lecture, British Burn Association) Burns 1979; 5: 149-159.
18. Jones RJ, Roe E, Gupta JL. Controlled trial of pseudomonal immunoglobulin and vaccine in burn patients. Lancet 1980; ii: 1263-1265.
19. Ayliffe GAJ, Lawrence JC Eds. Symposium on infection control in burns. J Hosp Infect 1985; 6: Suppl B.